KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lam Research (LRCX) EBT (2016 - 2025)

Lam Research (LRCX) has 17 years of EBT data on record, last reported at $1.8 billion in Q4 2025.

  • For Q4 2025, EBT rose 36.23% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $7.0 billion, up 43.39%, while the annual FY2025 figure was $6.0 billion, 36.65% up from the prior year.
  • EBT reached $1.8 billion in Q4 2025 per LRCX's latest filing, down from $1.9 billion in the prior quarter.
  • Across five years, EBT topped out at $1.9 billion in Q3 2025 and bottomed at $863.6 million in Q2 2023.
  • Average EBT over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2021.
  • Peak YoY movement for EBT: skyrocketed 84.27% in 2021, then plummeted 38.02% in 2023.
  • A 5-year view of EBT shows it stood at $1.4 billion in 2021, then rose by 21.81% to $1.7 billion in 2022, then plummeted by 34.2% to $1.1 billion in 2023, then rose by 24.02% to $1.3 billion in 2024, then soared by 36.23% to $1.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $1.8 billion in Q4 2025, $1.9 billion in Q3 2025, and $1.8 billion in Q2 2025.